CGP
Click for more information
6.78% 6.3¢ consegna group limited

Ann: Rhinomed to present at Microcap Investment S, page-15

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
  1. jasonobrien1984
    336 Posts.
    clock Created with Sketch.
    23/10/13
    09:18
    Post #: 12474114
    re: Ann: Rhinomed to present at Microcap Inve... This conference is happening today - looking forward to the added interest by investors/brokers/media on our product to market.

    Web link to event

    http://www.cvent.com/events/4th-annual-australian-microcap-investment-conference/event-summary-379c443a55734ea393f1fea43700451f.aspx

    Media coverage on previous conferences

    http://www.cvent.com/events/4th-annual-australian-microcap-investment-conference/custom-22-379c443a55734ea393f1fea43700451f.aspx

    CGP Price at posting: 6.5¢ Sentiment: ST Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Full funding secured for Pular lithium project development: joint venture nears completion
right-arrow Created with Sketch.
NEWS Drilling to kick off at high-priority Bara Creek Prospect, targeting a promising epithermal system near the Bowdens Silver Project
right-arrow Created with Sketch.
NEWS New gold and silver soil anomalies uncovered at Black Range, strengthening exploration potential
right-arrow Created with Sketch.
NEWS High-grade rock chip assays from Titan surface sampling exceed 55% gold and 1,000 g/t silver, unlocking significant exploration potential at this promising prospect
right-arrow Created with Sketch.
LU7 The Breakdown: Lithium Universe talks refinery design and lithium processing in strong preliminary feasibility study for Bécancour
right-arrow Created with Sketch.
RCE Phase II clinical trial recruitment for R327G topical gel passes halfway, showing promising results against bacterial skin infections
right-arrow Created with Sketch.
watchlist Created with Sketch. Add CGP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.